Glycated hemoglobin News and Research

RSS

Standard risk factors stratify already high-risk diabetic patients

Cardiovascular disease risk factors are associated with mortality even among patients with Type 2 diabetes who are already at high risk due to having high coronary artery calcified plaque, say researchers.

4 Jul 2014

Insulin pumps better than injections for glycaemic control in Type 2 diabetes

Patients with Type 2 diabetes achieve better glycaemic control with insulin pumps than multiple insulin injections, show the findings of the OpT2mise randomised trial.

4 Jul 2014

Diabetes easier to control with insulin pump than self-injections?

Insulin pump therapy may be an effective alternative for people who cannot control their diabetes effectively using daily self-injections, show study findings.

3 Jul 2014

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.

28 Jun 2014

Greenlander study identifies single mutation with large diabetes risk

Researchers have used a Greenlandic cohort to identify a genetic mutation whose effect on the risk of diabetes is “several times larger” than any previously discovered.

20 Jun 2014

Outpatient diabetes care quality matters after limb revascularisation

High quality outpatient diabetes care improves diabetic patients’ chances of avoiding major ischaemic events and amputation after undergoing limb revascularisation, a study shows.

16 Jun 2014

Canola bread diet experiences reduction in blood glucose levels and LDL cholesterol

Canola is Canada's oil and new research from St. Michael's Hospital suggests it should also be one of the oils of choice for people with Type 2 diabetes.

16 Jun 2014

Cardiac biomarkers aid microvascular risk prediction in diabetics

Assessing cardiac biomarkers results in a moderate improvement in the ability to predict microvascular complications in patients with Type 2 diabetes, say researchers.

6 Jun 2014

Improved glycemic control can slow progression of ESRD in type 1 diabetic people

People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.

6 Jun 2014

NCOA brings innovative online support program to help people manage type 2 diabetes

Under a unique collaboration, the National Council on Aging with support from the Bristol-Myers Squibb Foundation and WellPoint are—for the first time—bringing a proven and affordable face-to-face and online support program to help people manage their Type 2 diabetes.

6 Jun 2014

Glycaemic control crucial in first years after diabetes diagnosis

The largest deterioration in glycaemic control among patients with newly diagnosed Type 2 diabetes occurs in the first 2 years after diagnosis, research shows.

5 Jun 2014

Consistent glycaemic control wards off diabetic complications

Variability in glycaemic control is associated with both microvascular and macrovascular events in patients with Type 2 diabetes, shows an analysis of the ADVANCE trial.

23 May 2014

Intensive insulin has lasting benefits for diabetic MI survivors

Patients with diabetes given intensive insulin treatment following an acute myocardial infarction had improved survival over 20 years of follow-up of the DIGAMI 1 trial, report the investigators.

19 May 2014

Transition Therapeutics begins TT-401 Phase 2 clinical study for treatment of type 2 diabetes

Transition Therapeutics Inc. today announced the dosing of the first patient in a Phase 2 clinical study of TT-401 (LY2944876), a drug candidate for the treatment of type 2 diabetes.

15 May 2014

Isis Pharmaceuticals reports positive data from ISIS-GCGRRx Phase 2 study in patients with type 2 diabetes

Isis Pharmaceuticals, Inc. announced today positive data from a Phase 2 study of ISIS-GCGRRx in patients with type 2 diabetes uncontrolled on stable metformin therapy.

14 May 2014

Teaching people to self-manage diabetes leads to better results

Teaching people with diabetes how to control their blood glucose levels helps them achieve better results, finds a new study in Ethnicity and Disease. Surprisingly, providing intensive training to physicians of diabetes patients did not help patients achieve blood glucose control.

9 May 2014

Global risk assessment urged for hypertensive patients

Global risk assessment has a large impact on the risk stratification and therefore management of patients with hypertension, a study shows.

6 May 2014

Life expectancy after diabetic complications gauged

Researchers have generated an equation to estimate the probable life expectancies of patients with diabetes who experience a major complication.

2 May 2014

Young onset age heightens Type 2 diabetes complication risks

Patients who develop Type 2 diabetes before the age of 40 years have higher complication risks at any given age than those who develop it later in life, research shows.

28 Apr 2014

Alarming increases in diabetes and pre-diabetes cases in the U.S.

Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge. The researchers also found that the burden of the disease has not hit all groups equally, with alarming increases in diabetes in blacks, Hispanics and the elderly.

16 Apr 2014